Non-Invasive Respiratory Therapy Market Latest Updated Report 2023-2031

Non-Invasive Respiratory Therapy Market worth $3.61 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Non-Invasive Respiratory Therapy Market- (By Product (Non-invasive Positive-pressure Ventilator (PPV) (Bi-level Positive Airway Pressure Ventilator (BiPAP), Constant Positive Airway Pressure Ventilator (CPAP), Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)), Non-invasive Negative Pressure Ventilator (NPV)), By Application (Respiratory Distress Syndrome, Asthma & COPD, Others), By End-Use (Hospitals, Ambulatory Surgical Centers, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Non-Invasive Respiratory Therapy Market is valued at US$ 2.27 Bn in 2022, and it is expected to reach US$ 3.61 Bn by 2031, with a CAGR of 5.43% during the forecast period of 2023-2031.
Get Free Sample Copy of Report : https://www.insightaceanalytic.com/request-sample/2198

Non-invasive respiratory therapy encompasses a range of treatments and interventions aimed at improving respiratory function and relieving breathing difficulties without the need for invasive procedures. Non-invasive ventilators have become more portable and efficient in various care delivery situations. As a result, non-invasive ventilators have become a popular alternative for hospitals and individuals. Non-invasive ventilation has grown in popularity during the last two decades. Non-invasive ventilation is commonly used in critical care units and settings to treat chronic and acute respiratory insufficiency. Non-invasive ventilation has several advantages over invasive ventilation, including preventing artificial airway issues, a lower infection rate, a lesser requirement for sedative drugs, and a lower cost. The increased use of non-invasive ventilator systems for respiratory illnesses such as obstructive sleep apnea, general surgery, and trauma operations is expected to drive the non-invasive ventilator market over the projected period. The increased diagnosis rate of various respiratory disorders is expected to raise demand for therapeutic devices. Furthermore, technological breakthroughs in non-invasive and portable oxygen concentrators are propelling the global usage of these devices.

List of Prominent Players in the Non-Invasive Respiratory Therapy Market:
• ResMed Inc.
• Teleflex Incorporated
• Hamilton Medical
• Koninklijke Philips N.V.
• Heyer Medical AG
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Airon Corporation
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• Baxter International Inc.
• WILAmed GmbH
• Getinge AB
• Others

Market Dynamics:

Drivers-
Several factors are driving the non-invasive respiratory therapy market, including the rising prevalence of respiratory disorders, technological improvements, and a growing emphasis on patient comfort and safety. Furthermore, the increase in the number of surgeries performed across the globe is expected to raise demand for non-invasive ventilator consumables and disposables. The rise in demand for non-invasive ventilators due to an increase in complications connected with invasive ventilators among newborns and adult patients worldwide is expected to drive the non-invasive ventilators market growth.

Challenges:
Lack of information about the benefits and availability of non-invasive respiratory therapy options among patients and even certain healthcare practitioners is expected to restrain the market growth in the coming years. In addition, However, problems and adverse effects associated with ventilators, such as the risk of contracting pneumonia, may reduce device adoption, stifling market growth. Moreover, Non-invasive respiratory therapy devices, particularly advanced technology such as high-end CPAP and BiPAP machines, can be expensive. The initial expense may dissuade some healthcare facilities or patients from using these devices, especially in areas with low healthcare budgets.

Regional Trends:
The North America Non-Invasive Respiratory Therapy Market is expected to register a major market share in terms of revenue and it is projected to grow at a high CAGR in the near future. Several important variables influence the non-invasive respiratory therapy market in North America, fueling its growth and development. These drivers reflect the region's superior healthcare infrastructure, R&D skills, and growing emphasis on patient well-being. The rising frequencies of various respiratory disorders, as well as the increasing number of product approvals, are driving market expansion in the region. Moreover, the market in the region is being pushed primarily by an increase in the number of extremely ill COVID-19 patients in the United States, as well as the presence of leading manufacturers embracing output increases.

Curious About This Latest Version of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2198

Recent Developments:

• In June 2021, Medline Industries, Inc. ("Medline") acquired a substantial portion of Teleflex Incorporated's Respiratory business for $286 Bn in cash, less $12 Bn in working capital not transferred to Medline. The divestiture was finalized by Teleflex Incorporated, a leading global provider of healthcare supplies and services.
• In Nov 2020, Philips released a brand-new non-invasive ventilator specially made for people with COPD. With the Philips Ventilator BiPAP A40 EFL, healthcare professionals could easily check for and find expiratory flow limitation (EFL) to get the best homecare therapy.

Segmentation of Non-Invasive Respiratory Therapy Market-
By Product-
• Non-invasive Positive-pressure Ventilator (PPV)
o Bi-level Positive Airway Pressure Ventilator (BiPAP)
o Constant Positive Airway Pressure Ventilator (CPAP)
o Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)
• Non-invasive Negative Pressure Ventilator (NPV)
By Application-
• Respiratory Distress Syndrome
• Asthma & COPD
• Others
By End-Use-
• Hospitals
• Ambulatory Surgical Centers
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/non-invasive-respiratory-therapy-market/2198

Commercial Office Unit No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar,
Pune, Maharashtra 411028

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.